Development of new antitumor drugs and apoptotic signal transudation - Application to feline leukemia and canine lymphoma -

抗肿瘤新药开发及细胞凋亡信号转导-在猫白血病和犬淋巴瘤中的应用-

基本信息

  • 批准号:
    12460135
  • 负责人:
  • 金额:
    $ 9.22万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    2000
  • 资助国家:
    日本
  • 起止时间:
    2000 至 2001
  • 项目状态:
    已结题

项目摘要

Clinically, the combination treatment of solid tumor cells with an anticancer drug and radiation was widely used to enhance cell killing. 1-(3-C-Ethynyl-β-D-ribo-pentofuranosyl) cytosine (ECyd) and 2-chrolo-deoxyadenosine (Cl-Ade) was newly developed as anticancer drugs to induce cell death by inhibiting RNA synthesis. In this study, we examined whether the exposure of these anticancer drugs or /and ionizing radiation to human gastric adenocarcinoma MKN45 cells, human lekemia cell line MOLT-4 cells induce apoptosis and canine lymphoma cell line CL-1. In MOLT-4 cells, Fas expression and caspase 8/3 activation apoptotic cell death was observed after treatment of Cl-Ade, followed by apoptotic cell death. 2Cl-Ade and ECyd showed to induce apoptotic cell death in canine lymphoma cell CL-1 cells. MKN45 cells were treated with 0.1 μM ECyd for 1 h before irradiation. After irradiation with 20 Gy, apoptotic as well as swelling cells were morphologically discriminated by fluorescence microscopy … More combined with propidium iodide staining or electron microscopy and were scored. When cells were treated with ECyd alone, only 5 % of either apoptotic or necrotic cells appeared. When cells were exposed to X rays alone, about 5 % of apoptotic and about 45 % of swelling cells appeared. However, when cells were exposed to X rays in the presence of 0.1 μM ECyd, about 25 % of total cells was apoptotic cells and about 10 % of total cells was swelling cells. Apoptosis induced by treating cells with ECyd and X irradiation was significantly reduced by the treatment with Ac-DEVD-CHO (caspase 3 inhibitor) or TPCK (chymotrypsin-like protease inhibitor).These results suggested that caspase 3 and chymotrypsin-like proteases were responsible for apoptosis induced by co-treatment with ECyd and X rays. In this study, it was demonstrated that co-treatment of MKN45 cells with ECyd and X rays activated G2-phase-linked apoptotic signaling associated with caspase 3 and chymotrypsin like protease. These data may provide useful information to develop clinical treatment of radiation combined with anticancer drugs for solid tumors. Less
临床上,实体瘤细胞与抗癌药物和放射线的联合治疗被广泛用于增强细胞杀伤作用,1-(3-C-乙炔基-β-D-核糖-呋喃糖基)胞嘧啶(ECyd)和2-氯脱氧腺苷。 (Cl-Ade)是新开发的抗癌药物,通过抑制 RNA 合成来诱导细胞死亡。在这项研究中,我们检查了这些抗癌药物的暴露是否或/和。电离辐射对人胃腺癌MKN45细胞、人白血病细胞系MOLT-4细胞和犬淋巴瘤细胞系CL-1诱导细胞凋亡。在MOLT-4细胞中,观察到Fas表达和caspase 8/3激活后细胞凋亡。 Cl-Ade,随后是细胞凋亡,2Cl-Ade 和 ECyd 显示可诱导犬淋巴瘤细胞凋亡。 MKN45 细胞在照射前用 0.1 μM ECyd 处理 1 小时,用 20 Gy 照射后,通过荧光显微镜结合碘化丙啶染色或电子显微镜对凋亡和肿胀细胞进行形态区分并进行评分。当细胞单独用 ECyd 处理时,只有 5% 的细胞凋亡或坏死。当细胞单独暴露于 X 射线时,约 5% 出现凋亡,约 45% 出现肿胀细胞,然而,当细胞在 0.1 μM ECyd 存在下暴露于 X 射线时,约 25% 的细胞出现凋亡。凋亡细胞,约10%的细胞是肿胀细胞,用ECyd和X射线处理细胞诱导的细胞凋亡显着减少。 Ac-DEVD-CHO(半胱天冬酶 3 抑制剂)或 TPCK(胰凝乳蛋白酶样蛋白酶抑制剂)。这些结果表明,半胱天冬酶 3 和胰凝乳蛋白酶样蛋白酶是 ECyd 和 X 射线联合治疗诱导的细胞凋亡的原因。结果表明,ECyd 和 X 射线共同处理 MKN45 细胞可激活 G2 相相关的凋亡信号传导与caspase 3和糜蛋白酶样蛋白酶相比,这些数据可能为开发放射联合抗癌药物治疗实体瘤的临床治疗提供有用的信息。

项目成果

期刊论文数量(130)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
H.Abe ら: "Superoxide generation from human polymorphonuclear leukocytes by liposome encapsulated hemoglobin"Artif Cells Blood Substit Immobil Biotechnol. 29. 275-283 (2001)
H. Abe 等人:“通过脂质体封装的血红蛋白从人多形核白细胞中产生超氧化物”Artif Cells Blood Substit Immobil Biotechnol。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Kashiwakura et al.: "Effects of amifostine on the proliferation and differentiation of megakaryocytic progenitor cells"European Journal of Pharmacology. 437. 19-25 (2002)
Kashiwakura等人:“氨磷汀对巨核细胞祖细胞增殖和分化的影响”欧洲药理学杂志。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
稲浪 修 ら: "酸化ストレスと細胞内シグナル伝達"放射線科学. 43. 104-112 (2000)
Osamu Inanami 等人:“氧化应激和细胞内信号转导”放射学科学 43. 104-112 (2000)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Tsuji et al.: "Neuroprotective effect of α-phenyl-N-tert-butylnitrone in gerbil hippocampus is mediated by the mitogen-activated protein kinase pathway and heat shock proteins"Neuroscience Letters. 282. 41-44 (2000)
Tsuji 等人:“α-苯基-N-叔丁基硝酮在沙鼠海马中的神经保护作用是由丝裂原激活蛋白激酶途径和热休克蛋白介导的”神经科学快报 282. 41-44 (2000)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Yamamori et al.: "Roles of P38 MAPK, PKC and PI3-K in the signaling pathways of NADPH oxidase activation and phagocytosis in bovine polymorphonuclear leukocytes"FEBS Letter. 467. 253-258 (2000)
Yamamori 等人:“P38 MAPK、PKC 和 PI3-K 在牛多形核白细胞 NADPH 氧化酶激活和吞噬作用信号通路中的作用”FEBS Letter。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KUWABARA Mikinori其他文献

KUWABARA Mikinori的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KUWABARA Mikinori', 18)}}的其他基金

The defect of biodefense mechanisms in bovine leukocyte adhesion deficiency syndrome (BLAD) as observed from signal transduction pathway
从信号转导途径观察牛白细胞粘附缺陷综合征(BLAD)生物防御机制的缺陷
  • 批准号:
    09460133
  • 财政年份:
    1997
  • 资助金额:
    $ 9.22万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Steric visualization of diseased organs of laboratory small animals by three-dimensionally reconstructing MRI method
三维重建MRI方法对实验室小动物病变器官的立体可视化
  • 批准号:
    09556064
  • 财政年份:
    1997
  • 资助金额:
    $ 9.22万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Spin-trapping detection of nitric oxide (NO) production from macrophage during matuation
自旋捕获检测巨噬细胞成熟过程中一氧化氮 (NO) 的产生
  • 批准号:
    07660387
  • 财政年份:
    1995
  • 资助金额:
    $ 9.22万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Design of the MRI probe applicable to discrimination of the fine histological changes in brauns of laboratory animals
适用于辨别实验动物内脏细微组织学变化的MRI探头设计
  • 批准号:
    05556051
  • 财政年份:
    1993
  • 资助金额:
    $ 9.22万
  • 项目类别:
    Grant-in-Aid for Developmental Scientific Research (B)
Utilization of Spin-Trapping Reactions for Effective Detection of DNA Damage
利用自旋捕获反应有效检测 DNA 损伤
  • 批准号:
    04680207
  • 财政年份:
    1992
  • 资助金额:
    $ 9.22万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
Possibility of Electron Spin Resonance Spectroscopy as a Diagnostic Technique in Immunodeficiency Syndrome of Domestic Animals
电子自旋共振光谱作为家畜免疫缺陷综合症诊断技术的可能性
  • 批准号:
    01560333
  • 财政年份:
    1989
  • 资助金额:
    $ 9.22万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似国自然基金

超级增强子驱动hnRNP D介导脂代谢重编程促进外周T细胞淋巴瘤阿霉素耐药的机制研究
  • 批准号:
    82300218
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
双表观遗传药物联合PD-1抗体高效清除霍奇金淋巴瘤肿瘤微环境特征与互作调控
  • 批准号:
    82370228
  • 批准年份:
    2023
  • 资助金额:
    48 万元
  • 项目类别:
    面上项目
EB病毒过度激活STING通路抑制CD8+T细胞功能介导外周T细胞淋巴瘤免疫逃逸的机制研究
  • 批准号:
    82300211
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
结外鼻型NK/T细胞淋巴瘤免疫特征分析与临床转化研究
  • 批准号:
    82370199
  • 批准年份:
    2023
  • 资助金额:
    48 万元
  • 项目类别:
    面上项目
外泌体包裹溶瘤呼肠孤病毒通过CD20靶向治疗弥漫大B细胞淋巴瘤的作用机制研究
  • 批准号:
    82360044
  • 批准年份:
    2023
  • 资助金额:
    32 万元
  • 项目类别:
    地区科学基金项目

相似海外基金

Small-molecule degraders of STAT5
STAT5 的小分子降解剂
  • 批准号:
    10718129
  • 财政年份:
    2023
  • 资助金额:
    $ 9.22万
  • 项目类别:
Genetics and Genomics of Leiomyosarcoma (LMS): Improved understanding of cancer biology and new approaches to diagnosis and treatment
平滑肌肉瘤 (LMS) 的遗传学和基因组学:增进对癌症生物学和诊断和治疗新方法的了解
  • 批准号:
    10493627
  • 财政年份:
    2022
  • 资助金额:
    $ 9.22万
  • 项目类别:
Synthesis and evaluation of BTN3A1 ligands for cancer immunotherapy
用于癌症免疫治疗的 BTN3A1 配体的合成和评估
  • 批准号:
    10613486
  • 财政年份:
    2022
  • 资助金额:
    $ 9.22万
  • 项目类别:
Genetics and Genomics of Leiomyosarcoma (LMS): Improved understanding of cancer biology and new approaches to diagnosis and treatment
平滑肌肉瘤 (LMS) 的遗传学和基因组学:增进对癌症生物学和诊断和治疗新方法的了解
  • 批准号:
    10705677
  • 财政年份:
    2022
  • 资助金额:
    $ 9.22万
  • 项目类别:
First-in-class ETS inhibitor TK216: Translational Biology and Oral Dosage Form Development
一流的 ETS 抑制剂 TK216:转化生物学和口服剂型开发
  • 批准号:
    10259473
  • 财政年份:
    2021
  • 资助金额:
    $ 9.22万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了